Evolving Field of Molecular Testing in Non–Small Cell

Expert oncologists reflect on the current state of molecular testing in patients with non–small cell lung cancer and how it has impacted treatment pathways.

Related Keywords

, Treating Uncommon , Molecular Testing , Small Cell Lung Cancer , Nsclc , Non Small Cell Lung Cancer , Lung Cancer , Metastatic Lung Cancer , Metastatic Nsclc , Biomarker Testing , Tissue Testing , Tissue Biopsy , Liquid Biopsy , Ctdna Testing , Circulating Tumor Dna , Rna Testing , Rna Test , Immune Checkpoint Inhibitors , Immunotherapy , Targeted Therapy , Egfr Mutation , Walk Testing , Kras G12c , Met Alteration , Ntrk , Nccn Guidelines , Ngs Testing , Next Generation Sequencing ,